Why the study?
Type 1 diabetes is linked with atherothrombosis, but limited data exist regarding procoagulant activity in young individuals.
Does type 1 diabetes on intensified insulin treatment increase procoagulant activity in children and adolescents compared to healthy controls?
Does type 1 diabetes on intensified insulin treatment increase procoagulant activity in children and adolescents compared to healthy controls?
Children and adolescents with type 1 diabetes on intensive insulin therapy do not show increased procoagulant activity compared to healthy controls over 5 years, though elevated TFPI suggests increased endothelial activation related to hyperglycemia.
Answers are grounded in this paper and cite their sources.
No excess procoagulant activity in intensively treated youth with T1D; leaves open whether TFPI elevation marks endothelial activation warranting prospective CV studies.
Background Type 1 diabetes is associated with atherothrombosis, but limited data exist on procoagulant activity in the young. We investigated procoagulant activity in children/adolescents with type 1 diabetes using intensified insulin treatment compared with controls in a 5-year follow-up study, and further any associations with cardiovascular risk factors. Methods The study included 314 diabetes children/adolescents and 120 healthy controls. Prothrombin fragment 1+2 (F1+2), D-dimer, tissue-factor-procoagulant-activity (TF-PCA), and tissue-factor-pathway-inhibitor (TFPI) were analyzed with ELISAs. Results F1+2, D-dimer, and TF-PCA did not differ between the groups or correlate to HbA1c in the diabetes group at either time points. TFPI was significantly higher in the diabetes group compared with controls both at inclusion and follow-up (both P < .001). In the diabetes group, TFPI correlated significantly to HbA1c at both time points (r = 0.221 and 0.304, both P < .001). At follow-up, females using oral contraceptives had significantly elevated F1+2, D-dimer, and TF-PCA and lower TFPI compared to no-users (all P < .005), and females had lower TFPI (P = .017) and higher F1+2 compared with males (P = .052), also after adjusting for the use of oral contraceptives. Conclusions The current results show similar procoagulant activity in children/adolescents with type 1 diabetes compared with controls over a 5-year period, indicating that these children using modern intensified insulin treatment are not at high thrombotic risk at younger age. The elevated levels of TFPI in the diabetes group, related to hyperglycaemia, are probably reflecting increased endothelial activation. These findings highlight the significance of optimal blood glucose control in children/adolescents with type 1 diabetes, to maintain a healthy endothelium.
No takes yet. Share an insight, caveat, or question.
Bratseth et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: